Low-density lipoprotein size in primary hypothyroidism. Effects of hormone replacement therapy

Annals of Nutrition and Metabolism

Volumn 43, Issue 6, 1999, Pages 374-379

  Roscini, Anna Rita ^a   Lupattelli, Graziana ^b   Siepi, Donatella ^b   Pagliaricci, Sergio ^b   Pirro, Matteo ^b   Mannarino, Elmo ^b  

^a POLICLINICO MONTELUCE   (Italy)

^b NONE

Author keywords

Hormone replacement therapy; Hypothyroidism; Low density lipoprotein size

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HORMONE SUBSTITUTION; HUMAN; HYPOTENSION; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033501683     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012806     Document Type: Article

References (30)

1. Abrams JJ, Grundy SC, Ginsberg H: Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. J Lipid Res 1980; 22:307-321.
2. O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ: Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993;68:860-866.
3. Abrams JJ, Grundy SM: Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res 1981;22:323-338.
4. Gammage M, Franklyn J: Hypothyroidism, thyroxine treatment and heart. Heart 1997;77:189-190.
5. Diekman T, Lansberg PJ, Kastelein JP, Wiersinga WM: Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 1995;155:1490-1495.
6. Oettengen P, Ginsburg G, Horowitz G, Pasternak R: Frequency of hypothyroidism in adults with serum total cholesterol levels >200 mg/dl. Am J Cardiol 1994;73:955-957.
7. Lardener CD, Fortmann SP, Krauss RM: Association of small low density lipoprotcin particle with the incidence of coronary artery disease in men and women. JAMA 1996;276: 875-881.
8. Miller BD, Aldermann EL, Haskel W, Fair JM, Krauss RM: Predominance of dense low density lipoprotein particle predicts angiographic benefit of therapy in the Stanford coronary risk intervention project. Circulation 1996;94:2146-2153.
9. Krauss RM: Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1994;5:339-349.
10. Nishina PM, Johnson JP, Naggert JK. Krauss RM: Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA 1992; 89:708-712.
11. Rotter JL, Bu X, Cantor R, Warden CH, Xia YR, DeMeester C, Teryua S, Lokensgard B, Daneshmand S, Brown J. Gray RJ, Kraus RM, Lusis AJ: Multilocus genetic determination of LDL particle size in coronary artery disease families (abstract). Clin Res 1994;42:16.
12. Austin MA: Genetic and environmental influences on LDL subclass phenotypes. Clin Genet 1994;46: 64-70.
13. Rainwater DL, Andres DW, Ford AL, Lowe WF, Blanke PJ, Krauss RM: Production of polyacrilamide gradient gels for the electrophoretic resolution of lipoproteins. J Lipid Res 1992;33:1876-1881.
14. Griffin BA, Freeman DJ, Tait GW: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfraction: Relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-253.
15. Austin MA, King MC, Vranizan KM: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease. Circulation 1990;82:495-506.
16. Jokinen EV, Landschulz KT, Wine KL, Ho YK, Frykman PK, Hoobs HH: Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 1994;269:26411-26418.
17. Hudig F, Bakker O, Wiersinga WM: Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA. FEBS Lett 1994;341:86-90.
18. Wiseman S, Powell J, Humphries SE, Press M: The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. J Clin Endocrinol Metab 1993;77:108-112.
19. Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P: Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol (Copenh) 1983; 104:50-56.
20. Lam KS, Chan MK. Yeung RT: High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction: Effects of treatment. Q J Med 1986;59:513-521.
21. Bruce A, Packard CJ: Metabolism of VLDL and LDL subclasses. Curr Opin Lipidol 1994;5:200-206.
22. Zambon A, Austin MA, Brown BG: Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993;13:147-153.
23. Watson TDG, Caslake MJ, Freeman DJ, et al: Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Atherioscler Thromb 1994;14:902-910.
24. Klausen C, Nielsen EF, Hegedus L, Gerdes LU, Charles P, Faergeman O: Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a). Metabolism 1992;41:911-914.
25. De Bruin TW, van Berlingen H, van Lindesibenius Trip M, van Vurst de Vries, Akveld JM, Erkelens WD: Lipoprotein(a) and apolipoprotein B plasma concentration in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 1993;76:121-126.
26. Marcovina SM, Morriset JD: Structure and metabolism of lipoprotein(a). Curr Opin Lipidol 1995;6: 136-145.
27. Ritter MM, Geiss HC, Richter WO, Schwandt P: Lipoprotein(a) concentration and phenotypes in controls and patients with hypercholeslerolemia or hypertriglyceridemia. Metabolism 1994;43:572-578.
28. Kraft HG, Menzel HJ, Hoppichler F. Vogel W, Uterman G: Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest 1989;83:137-142.
29. Davidson NO, Carlos RC, Lukaszewicz AM: Apolipoprotein B mRNA editing is modulated by thyroid hormone but not growth hormone administration in the rat. Mol Endocrinol 1990;4:779-785.
30. Davidson NO, Powel LM, Wallis SC, Scott J: Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J Biol Chem 1988; 263:13482-13485.